Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Reinvestment Rate
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Reinvestment Rate of 0.50x as of September 2022, reinvesting CN¥155.73 Million (capex CN¥119.58 Million plus investments CN¥36.14 Million) from operating cash flow of CN¥309.89 Million. Check Zhejiang Orient Gene Biotech Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Explore 688298 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Zhejiang Orient Gene Biotech Co Ltd. For live market cap and broader valuation context, see market cap of Zhejiang Orient Gene Biotech Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.71x | CN¥2.13 Billion | CN¥3.00 Billion | CN¥1.05 Billion | ▲ +402.2% |
| 2021 | 0.14x | CN¥736.03 Million | CN¥5.20 Billion | CN¥507.87 Million | ▼ -55.1% |
| 2020 | 0.31x | CN¥563.93 Million | CN¥1.79 Billion | CN¥126.93 Million | ▼ -96.2% |
| 2019 | 8.28x | CN¥448.90 Million | CN¥54.21 Million | CN¥11.90 Million | ▼ -19.5% |
| 2018 | 10.28x | CN¥455.88 Million | CN¥44.33 Million | CN¥18.88 Million | ▼ -23.4% |
| 2017 | 13.43x | CN¥450.38 Million | CN¥33.54 Million | CN¥13.38 Million | ▲ +76.0% |
| 2016 | 7.63x | CN¥90.11 Million | CN¥11.81 Million | CN¥4.65 Million | — |